METTL3 mediates atheroprone flow–induced glycolysis in endothelial cells
Proceedings of the National Academy of Sciences · 13.05.2025 · 122 (19)
DOI: 10.1073/pnas.2424796122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 06.05.2025. Verfasst von Guo-Jun Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Hauptthemen laut MEDLINE: Methyltransferases, Glycolysis, Atherosclerosis, Endothelial Cells. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health National Heart, Lung and Blood Institute, National Natural Science Foundation of China.
Abstract (Originalsprache)
Atheroprone flow–increased glycolysis in vascular endothelial cells (ECs) is pivotal in EC dysfunction and the initiation of atherosclerosis. Methyltransferase 3 (METTL3) is a major m 6 A methyltransferase for RNA N6-mehtyladenosine (m 6 A) modifications to regulate epitranscriptome and cellular functions. With the atheroprone flow upregulating METTL3 and m 6 A RNA hypermethylation, we investigate the role of METTL3 in atheroprone flow–induced glycolysis in ECs in vitro and in vivo. Compared to pulsatile shear stress (PS, atheroprotective flow), oscillatory shear stress (OS, atheroprone flow) increases METTL3 expression to enhance the m 6 A modifications of mRNAs encoding HK1, PFKFB3, and GCKR, which are rate-limiting enzymes of glycolysis. These augmented m 6 A modifications increase the expressions of HK1 and PFKFB3 while decreasing GCKR, resulting in elevated EC glycolysis, as revealed by seahorse analysis. Moreover, a stimulated Raman scattering (SRS) imaging study demonstrates the elevation of glucose incorporation into de novo synthesized lipids in ECs under atheroprone flow in vitro and in vivo. Empagliflozin, a sodium-glucose cotransporter-2 inhibitor (SGLT2i) drug, represses METTL3 expression, thereby mitigating OS-induced glycolysis in ECs. These data suggest mechanisms by which METTL3 links EC mechanotransduction with metabolic reprogramming under atherogenic conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Division of Cardiology, Department of Medicine, University of California, La Jolla, CA 92093.
- Department of Bioengineering, University of California at San Diego, La Jolla, CA 92093.
- Institute of Engineering in Medicine, University of California, La Jolla, CA 92093.
- Department of Diabetes Complications and Metabolism, Beckman Research Institute, City of Hope, Duarte, CA 91010.
ORCID-Profile: Shu Chien
Förderung
- NHLBI NIH HHS
- National Institutes of Health National Heart, Lung and Blood Institute
- National Natural Science Foundation of China
Zitieren
APA
Zhao, G. J., Han, S. Y., Li, Y., Yuan, D., Qin, S., Li, Y., Jang, H., Chen, L. J., Wei, T. W., He, M., Li, Y. S., Bouman Chen, Z., Shi, L., Chien, S., & Shyy, J. Y. (2025). METTL3 mediates atheroprone flow–induced glycolysis in endothelial cells. Proceedings of the National Academy of Sciences, 122(19). https://doi.org/10.1073/pnas.2424796122
Vancouver
Zhao GJ, Han SY, Li Y, Yuan D, Qin S, Li Y, et al. METTL3 mediates atheroprone flow–induced glycolysis in endothelial cells. Proceedings of the National Academy of Sciences. 2025;122(19). doi:10.1073/pnas.2424796122
BibTeX
@article{Zhao2025,
author = {Zhao, Guo-Jun and Han, So Yun and Li, Yajuan and Yuan, Dongqiang and Qin, Shuo and Li, Yuhan and Jang, Hongje and Chen, Li-Jing and Wei, Tong-You Wade and He, Ming and Li, Yi-Shun and Bouman Chen, Zhen and Shi, Lingyan and Chien, Shu and Shyy, John Y-J},
title = {METTL3 mediates atheroprone flow–induced glycolysis in endothelial cells},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {19},
doi = {10.1073/pnas.2424796122}
}
EUVIMED